Page not found
Search results
-
CTTC commercialized 25 COVID-19-related discoveries, facilitated nine startups during record-setting year
... companies in 2020. Amid the myriad challenges of that year, CTTC successfully evaluated, marketed and licensed new inventions, conducted ... to treat early-stage Parkinson’s disease. The company was co-founded by Dr. David Charles , professor and vice chair of neurology at ...
sommers - 05/26/2021 - 10:39am
-
GNVCA hires eminent association leader as inaugural executive director
... an account executive with Hall Strategies, a Nashville-based public affairs and government relations firm and was Tennessee communication ...
sommers - 03/28/2024 - 8:39am
-
Oral administration of levocarnitine for treating Sjögren's Syndrome-associated dry eye
... Additional document url: /sites/default/files/marketing_projects_attachments/MKT19065.pdf ...
cttc_admin - 02/15/2024 - 1:31pm
-
Wolbachia genetic tools for population control of harmful insects
... Additional document url: /sites/default/files/marketing_projects_attachments/MKT16060c.pdf ...
cttc_admin - 02/15/2024 - 1:30pm
-
Continuum Robots with Equilibrium Modulation (CREM)
... Additional document url: /sites/default/files/marketing_projects_attachments/MKT17117.pdf ...
cttc_admin - 02/14/2024 - 8:48am
-
Portfolio of Continuum Robotic Systems, Algorithms, and Software Technologies from the Robotics Lab of Professor Nabil Simaan
... Additional document url: /sites/default/files/marketing_projects_attachments/VU17117A.pdf ...
cttc_admin - 02/14/2024 - 8:48am
-
Vanderbilt University School of Medicine ranks in the top 10 for grant support provided by the NIH in FY23
... exceeding $45 billion, the NIH is the world’s largest public funder of biomedical research. The Blue Ridge rankings are derived from ...
sommers - 03/18/2024 - 9:26am
-
A “public” target for HIV
... Host & Microbe, suggest that a number of common or “public” HIV-reactive antibody sequences can be detected in multiple ...
sommers - 06/29/2018 - 2:21pm
-
Tech Connect, Vol. 6, Issue 7: Collaboration seeks to develop new therapies for bone and other diseases
... to clinical development. La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement ... looks familiar, there's a good reason! Earlier this week, CTTC released its annual Inventor Satisfaction Survey. 2015 ...
steelmk - 11/15/2016 - 4:11pm
-
Low-Frequency Strain Energy Harvester
... Additional document url: /sites/default/files/marketing_projects_attachments/MKT18017.pdf ...
cttc_admin - 02/02/2024 - 4:41pm